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A B S T R A C T
Cat scratch disease (CSD), the typical clinical manifestation of Bartonella infections usually 
follows a typical benign self-limited course. Nevertheless, a variety of unusual clinical 
manifestations and confusing imaging features can lead to misinterpretations and render the 
disease a diagnostic dispute. Routine laboratory tests exhibit varying reported sensitivity and 
are usually unhelpful in diagnosis, as serology fails in terms of specificity and/or sensitivity. 
Herein we report a case of seronegative Bartonella infection presenting as symptomatic 
suppurative lymphadenitis with abscess formation, which was surgically drained. Diagnosis 
was established by PCR analysis from lymph nodes samples obtained during the procedure. 
PCR detection of specific DNA fragments from lymph node biopsy provides a sensitive 
detection of disease. The technique should be considered for patients with suspected CSD and 
negative serology, since serological assays exhibit low sensitivity. In ambiguous cases, surgical 
exploration may provide tissue for diagnosis; it is well tolerated and affords improved recovery. 
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Introduction
History of animal contact, regional lymphadenopathy and 
constitutional symptoms comprise the typical presentation 
of cat scratch disease (CSD), an infectious disease caused 
nearly exclusively by Bartonella henselae, a Gram-negative 
coccobacillus. Most patients report recent contact with a cat, 
usually a kitten. The typical course is usually benign and 
self-limited and in most cases requires only supportive 
therapy. Imaging and serological studies in correlation with a 
clinical history of cat contact may facilitate the diagnosis and 
avoid unnecessary invasive procedures.
However, the imaging features of lymphadenopathy 
in CSD may be confusing.1 In addition, a variety of other 
unusual localized or systemic clinical manifestations can 
lead in some occasions to misinterpretations2,3 and render 
the disease a diagnostic dispute. Although serologic analysis 
is the most extensively evaluated minimally invasive 
diagnostic technique for the diagnosis of CSD, the sensitivity 
of serologic tests varies from one laboratory to another 
ranging from nearly 100% to < 30%.4,5 Consequently, the 
disease can involve a prolonged and/or complicated course 
and further invasive diagnostic procedures can be required, 
as in our case.
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Case report
A 34-year-old Caucasian male patient was admitted to our 
hospital with pain and swelling in the left axilla and elbow, 
and a history of pyrexia for the past 2 months. The patient 
was an urban inhabitant, had a free medical history and was 
not receiving any medications. He denied promiscuous sexual 
behaviors or drug abuse. He was not a domestic animal owner 
and denied having been in contact with animals.
Upon physical examination, the patient’s temperature 
was 38.4oC. Two maculopapular erythematous skin rashes, 
with underlying tender and very painful palpable masses 
resembling lymphadenopathy were present at the axillary and 
the left epitrochlear regions (Fig. 1A). No scars or scratches 
were present at the left upper arm.
Laboratory work up showed normal hemoglobin, an 
elevated white blood cell count (15600 cells/mm3; 68% 
neutrophils, 22% lymphocytes, 5% monocytes 1% basophils 
and 4% eosinophils). Liver enzymes were normal and 
C-reactive protein levels were 1.45 mg/L. Blood cultures 
and viral serologic test results were all negative. Moreover, 
serological tests were used to exclude Chlamydia trachomatis, 
EBV, CMV and HIV infection. Chest radiograph showed no 
particular findings. Computed tomography of the chest 
(Fig. 1B) revealed a well-enhanced soft tissue lesion over the 
left axillary region, measuring 4.0 x 3.5 cm (arrow), resembling 
a necrotizing lymphadenitis of the axilla with no signs of 
abscess formation.
Cat scratch disease was suspected, but serological tests 
by means of in house indirect fluorescence assay (IFA) 
against Bartonella quintana and Bartonella henselae gave 
negative results. Despite the negative serology, azithromycin 
(500 mg the first day and 250 mg for the next four days) was 
administered. Regardless of antibiotic treatment the axillary 
mass lymphadenopathy showed no signs of resolution, while 
the laboratory inflammatory signs and fever persisted for the 
following 5 days.
Surgical exploration of the lesions was resorted to as 
a diagnostic procedure and revealed two abscesses at the 
epitrochlear and axillar region, respectively. Both abscesses 
were present within a cluster of enlarged lymph nodes, 
they were both drained, and pus was sent for culture. 
A sample of lymph nodes was sent for histological exami-
nation and PCR assay.
Pathological findings demonstrated granulomatous 
inflammations with stellate necrosis suggesting CSD 
as one of the possible diagnosis (Fig. 2). Culture results 
were negative for microbial growth. Gram staining and 
Warthin-Starry silver staining were also negative. The final 
diagnosis was established by lymph node samples sent for 
PCR analysis (16S rRNA gene amplification), which revealed 
the presence of B. henselae DNA in the specimen. 
Postoperative, the high-grade fever resolved spontaneously 
and the laboratory findings showed remission of the 
inflammatory signs. The patient was discharged on 
the second postoperative day. No additionally work up 
was performed during his follow-up and two months later 
the patient was considered cured.
Fig. 1 - (A) Photograph of the axillary and the left 
epitrochlear regions, showing the maculopapular 
erythematous skin rashes. Tender and very painful 
palpable masses were present at the underlying tissues 
resembling lymphadenopathy. (B) CT of the axillary region, 
showing a 4.0 x 3.5 cm soft tissue lesion at the left axilla 
(arrow), with no signs of abscess formation.
Fig. 2 - (A) Lymphadenitis with central necrosis and 
neutrophilic aggregation. (B) Higher-power view of necrotic 
granuloma in axillary lymph node, rimmed by epithelioid 
histiocytes, multinucleated giant cells, lymphocytes and 
eosinophils. (Haematoxylin and eosin staining, x100).
Discussion
Culture of Bartonella spp. from human specimens is very 
difficult. Therefore, clinical suspicion for CSD is usually 
confirmed serologically by the detection of antibodies 
against B. henselae or by the detection of Bartonella DNA in 
affected tissue. 
Serological testing (mainly IFA) is the first and most 
practical diagnostic tool towards laboratory detection of 
suspected CSD,5 although it exhibits variability, as many 
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different tests are available. The sensitivities of different IFAs 
range from 14% to 100%, depending on the antigen used, the 
cut-off chosen, and the test procedures.5-7
An IgM titer of 1:16 or higher indicates acute disease, 
with 3-month duration of detection in 50% of patients.6,8,9 
Thus, IgM antibodies are infrequently detected in serology 
and negative results do not rule out acute disease. An IgG 
titer higher than 1:256 is considered evidence of current or 
past Bartonella infection. Titers of 1:64 to 1:128 are considered 
equivocal. IgG titers also decrease with time; 75% of patients 
become seronegative after 1 year. There are reported 
decreases in IgG titer even after 4 weeks in some cases.5,10 
However, when IgG antibodies persist for up to a year, it is 
difficult to differentiate and diagnose active infection versus 
previous exposure to the bacterium.
Evidence shows that some patients never mount a 
detectable antibody response and that 88% of patients 
suspected of having CSD have detectable antibody, 
versus 3% of healthy controls.11 Thus, disadvantages 
of serologic diagnosis include variable sensitivity and 
specificity and inability to distinguish between active 
and prior infection.12,13 In addition, due to the lack of 
Bartonella  species-specific antibody response, cross-
reactivity between different Bartonella spp., Epstein-Barr 
virus, cytomegalovirus, Toxoplasma gondii and Streptococcus 
pyogenes may occur.12,14,15
Concerning histopathological examination of affected 
lymph nodes to determine the cause of lymphadenopathy, 
there is no specific pathology suggestive for B. henselae 
infection.12 Even when Warthin-Starry silver stain is 
used to identify the causative bacterium, histopathologic 
findings are strongly suggestive for CSD but not definitive.16 
Nevertheless, histopathologic examination of affected lymph 
nodes is crucial when other malignant or granulomatous 
diseases (such as brucellosis, tuberculosis, lymphogranuloma 
venereum, histoplasmosis or coccidioidomycosis) and HIV 
infection have to be ruled out.17
Advanced diagnostic techniques such as PCR on lymph 
node or other material have been applied to the detection 
of Bartonella. Detection of B. henselae DNA in blood may 
prove useful, especially in cases where lymphadenectomy 
or biopsy is not feasible or serological results are ambiguous. 
PCR provides the advantages of high specificity and rapid 
identification, however lacking in sensitivity, ranging from 
43% to 76%.12,18,19 The sensitivity of PCR with samples 
of lymph node tissue or aspirates is 30-60% for CSD. PCR 
amplification can be also performed with pus samples drawn 
from lymph nodes with a reported sensitivity between 58 
and 96%, therefore a lymph node biopsy can be avoided.20-23 
However, pus can only be collected from approximately 15% 
of the patients as 10 to 35% of the infected nodes progress to 
suppuration.20,24
In our case, despite the fact that the patient denied 
having been in contact with animals, clinical suspicion 
regarding CSD was raised. Nevertheless, IFAs were not helpful 
in establishing the diagnosis. The CT imaging resembling 
a soft – tissue necrotizing infection and lymphadenopathy 
was also not typical for Bartonella infection.5 It has been 
proposed that a minority of patients with cat-scratch disease 
may actually require surgical drainage of a symptomatic 
abscess and lymph node sampling. Between 10 and 35% 
of the infected nodes progress to suppuration and evacuating 
the pus is necessary in this condition.24 Suppurative tense 
and painful nodes should be drained, while incision of non-
suppurative lesions should be avoided, as chronic draining 
fistulae or compromised healing may result.4,5,25,26 As the 
clinical status of our patient was not improving despite 
antibiotic treatment, the use of an invasive approach 
was rendered necessary. Surgical exploration revealed 
the abscesses not clearly depicted by the CT. Despite the 
reported low sensitivity, the final diagnosis in our patient 
was established by PCR.
In cases where manifestations of CSD as lymphadenopathy 
or abscesses are self-limited, most patients have gradual 
resolutions of symptoms even without antibiotic treatment. 
Azithromycin treatment can be considered for patients with 
significant lymphadenopathy. In complicated Bartonella 
infections on immunocompromised patients, there is 
a dramatic response to antibiotics. Thus, seriously ill 
immunocompetent individuals are treated with similar 
regimens despite the lack of data.12,27
In conclusion, despite advances in diagnostic means, the 
diagnosis of CSD may still be challenging. Cat scratch disease 
should be considered in patients with chronic (> 3 weeks) 
lymphadenopathy. Given the low sensitivity of the serological 
assays, PCR analysis for B. henselae should be considered 
for patients with suspected CSD and negative serology. In 
ambiguous cases like ours, careful surgical exploration may 
provide tissue for diagnosis. It is well tolerated, and affords 
improved recovery with minimal complications.
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